CATALOGO DEI PRODOTTI DELLA RICERCA

GAMBARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.927
EU - Europa 7.589
AS - Asia 3.068
OC - Oceania 25
SA - Sud America 18
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.905
CN - Cina 2.103
GB - Regno Unito 1.933
IE - Irlanda 1.076
FR - Francia 1.048
RU - Federazione Russa 816
SE - Svezia 693
SG - Singapore 678
IT - Italia 661
DE - Germania 496
FI - Finlandia 406
UA - Ucraina 325
VN - Vietnam 52
JP - Giappone 39
BE - Belgio 36
KR - Corea 33
IN - India 31
PK - Pakistan 28
AU - Australia 21
HK - Hong Kong 21
TR - Turchia 20
CA - Canada 18
NL - Olanda 14
GR - Grecia 13
IL - Israele 12
RO - Romania 10
ID - Indonesia 9
BR - Brasile 8
CH - Svizzera 8
ES - Italia 8
SK - Slovacchia (Repubblica Slovacca) 7
IR - Iran 6
NO - Norvegia 6
PL - Polonia 6
AT - Austria 5
DK - Danimarca 5
CL - Cile 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BD - Bangladesh 3
HR - Croazia 3
IQ - Iraq 3
LB - Libano 3
MX - Messico 3
SA - Arabia Saudita 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
PR - Porto Rico 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 19.639
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.015
Southend 1.757
Chandler 1.325
Dublin 1.074
Woodbridge 754
Ashburn 659
Houston 470
Singapore 420
Lawrence 417
Princeton 417
Ann Arbor 405
Beijing 389
Wilmington 369
Jinan 215
Nanjing 175
Shenyang 149
Sindelfingen 136
New York 135
Verona 131
Hebei 113
Redmond 93
Tianjin 91
Seattle 83
Helsinki 73
Milan 69
Nanchang 69
Changsha 64
Zhengzhou 62
Ningbo 61
Boardman 60
Haikou 60
Norwalk 58
Taizhou 50
Guangzhou 48
Taiyuan 44
Jiaxing 42
Redwood City 42
Fairfield 38
Brussels 36
Tokyo 36
Hangzhou 31
Dallas 27
Lanzhou 26
Dong Ket 25
Lancaster 25
Chicago 24
Dongguan 23
Falls Church 23
Fuzhou 23
Kent 19
Washington 19
Bologna 18
Seoul 18
Mianwali 17
San Diego 17
Hong Kong 15
Hyderabad 15
Los Angeles 15
Shenzhen 14
Tappahannock 14
Genova 13
London 13
San Francisco 13
Rome 12
Toronto 12
Venice 12
Dearborn 11
Düsseldorf 11
Florence 11
Lappeenranta 10
Saint Petersburg 10
Auburn Hills 8
Edinburgh 8
Mehlingen 8
Phoenix 8
Sommacampagna 8
Bonndorf 7
Catanzaro 7
Bratislava 6
Cambridge 6
Detroit 6
Frankfurt am Main 6
Fremont 6
Madrid 6
Malda 6
Moscow 6
Oslo 6
Padova 6
Radeberg 6
Trento 6
Warsaw 6
Zurich 6
Adelaide 5
Canberra 5
Clearwater 5
Dera Ismail Khan 5
Gangnam-gu 5
Melbourne 5
Paris 5
Vienna 5
Totale 13.418
Salva come PNG Salva come JPEG
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 369
Placche di Randall e calcolosi ossalo-calcica idiopatica: quale ruolo e quale futuro? 201
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 166
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 162
Age dependence of within-subject biological variation of nine common clinical chemistry analytes 123
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 101
mTOR inhibitors and renal allograft: Yin and Yang. 101
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 92
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 92
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 92
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 92
Sulodexide and glycosaminoglycans in the progression of renal disease. 90
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. 89
Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. 89
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 88
QUANTITATION OF TGF-BETA1 mRNA IN PORCINE MESANGIAL CELLS BY COMPARATIVE KINETIC RT/PCR: COMPARISON WITH RIBONUCLEASE PROTECTION ASSAY AND IN SITU HYBRIDIZATION. 87
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 87
ADVANCES IN REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ANALYSIS OF CELLULAR mRNA LEVELS OF TRANSFORMING GROWTH FACTOR-BETA1 BY CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION. 86
LIVER-KIDNEY-TRANSPLANTATION IN TYPE 1 PRIMARY HYPEROXALURIA: DESCRIPTION AND COMMENTS ON A CASE. 86
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 85
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 84
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 83
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 83
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 83
A validated model of disease progression in IgA nephropathy. 82
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 82
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 82
Renin-angiotensin system (RAS) DNA polymorphisms and TGFbeta1-mediated fibrogenetic pathway gene expression studies in primary IgA naphropathy (Berger’s disease). 81
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 81
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 80
Detection of a large deletion in the P-selectin (SELP) gene 80
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 80
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 80
Directional dominance on stature and cognition in diverse human populations. 80
Glycosaminoglycan therapy for long-term diabetic complications? 79
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 79
Medullary sponge kidney: state of the art. 79
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 79
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 78
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 78
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 78
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. 77
Call for prospective studies of cystatin C. 77
ABNORMAL ARACHIDONIC ACID CONTENT OF MEMBRANE PHOSPHOLIPIDS- THE UNIFYING HYPOTHESIS FOR THE GENESIS OF HYPERCALCIURIA AND HYPEROXALURIA IN IDIOPATHIC CALCIUM NEPHROLITHIASIS. 77
Does Randall’s plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? 77
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 77
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function 77
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. 76
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients. 76
Lithiasis in cystic kidney disease and malformations of the urinary tract. 76
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 76
Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. 75
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 75
Predictive model for delayed graft function based on easily available pre-renal transplant variables 75
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 75
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 75
General practitioners' serum creatinine recording styles. 74
Placche di Randal e calcolosi ossalocalcica idiopatica: quale ruolo e quale futuro? 74
Unusual renal presentation of Fabry disease in a female patient. 73
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 73
Renal Stones in Medullary Sponge Kidney: Effect of Treatment with Alkali Citrate and Recognition of two Clinical Phenotypes. 73
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 73
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 72
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 72
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 72
Association studies of genetic polymorphisms and complex disease. 71
Silent chronic kidney disease epidemic seen from Europe: designing strategies for clinical management of the early stages. 71
GLYCOSAMINOGLYCAN PREVENTS HYPERGLYCEMIA-INDUCED RENAL TGF-BETA 1 GENE EXPRESSION. 71
Henoch-Schonlein purpura and Crohn's disease in a family. 71
Placche di Randall, familiarità per calcolosi e numerosità di eventi litiasici: esiste una correlazione ? 71
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 71
Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis. 70
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 70
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 70
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 70
Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? 69
GAPDH as housekeeping gene at renal level. 68
Modulation of genetic associations with serum urate levels by body-mass-index in humans. 68
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 68
Donor-transmitted cancer in kidney transplant recipients: a systematic review 68
Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. 67
Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. 67
Heparanase as a target in cancer therapy. 67
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE Study (in press) 66
Small effective population size and genetic homogeneity in the Val Borbera isolate 66
Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes. 66
GLUT-1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy. 66
LOW-MOLECULAR-WEIGHT HEPARIN PREVENTS HIGH GLUCOSE- AND PHORBOL ESTER-INDUCED TGF-BETA 1 GENE ACTIVATION. 66
Citrate therapy in Dent's disease. 66
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. 65
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 65
Liver-kidney-transplantation in type 1 primary hyperoxaluria: description and comments on a case. 64
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. 64
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 64
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes 64
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. 63
Risk for renal failure in nephrolithiasis. 63
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 63
Gene expression analysis in microdissected renal biopsy. 63
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis. 63
Totale 8.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.279
article - articoli 80.546
book - libri 0
conference - conferenze 2.924
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.809
Totale 172.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.749 0 0 17 185 83 421 125 162 77 191 81 407
2020/20212.784 307 395 65 320 377 376 35 203 161 32 372 141
2021/20222.210 109 498 12 194 75 27 38 187 107 113 138 712
2022/20234.960 494 381 676 609 536 1.278 27 277 445 30 138 69
2023/20242.870 105 226 247 232 277 404 73 559 27 90 386 244
2024/20251.136 478 577 81 0 0 0 0 0 0 0 0 0
Totale 20.167